BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

RecomGenex, Ltd. Announces Research Collaboration With AstraZeneca (AZN)


10/19/2005 5:09:42 PM

BUDAPEST, Hungary, Jan. 16 /PRNewswire/ -- RecomGenex Ltd. announced today that they have entered into a research collaboration with AstraZeneca AB to produce unique functional nuclear receptors to be used for research purposes.

Applying their proprietary RefoldAll(TM) protein renaturation technology to inclusion bodies provided by AstraZeneca, RecomGenex will determine optimal conditions needed to properly fold these complex proteins so they demonstrate full functionality. Under terms of the collaboration, resulting proteins will be owned exclusively by AstraZeneca.

"This collaboration allows us to demonstrate the power of our RefoldAll(tm) technology in solving difficult protein refolding problems experienced in the expression of complex proteins," said Geza Ambrus-Aikelin, CEO of RecomGenex.

About RecomGenex, Ltd.:

RecomGenex is subsidiary of ComGenex, an integrated discovery service provider for the pharmaceutical and biotechnology industries. RecomGenex offers proprietary protein expression services including refolding, while ComGenex offers proprietary services and methods in the area of chemistry, instrumentation, high-throughput analytics, informatics and ADME. The company has a proven track record of successful collaborations with major pharmaceutical, chemical and biotechnology companies. Commercially, RecomGenex offers clients 'off the shelf' services and collaborative development in the field of protein research.

RecomGenex Ltd.

CONTACT: Geza Ambrus-Aikelin, Chief Executive Officer, +36-1-214-2306,ambrus@recomgenex.com, or William P. Heilman, PhD, Head of BusinessDevelopment, +1-732-438-8001, william.heilman@recomgenex.com, both ofRecomGenex Ltd.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES